Lorenz Höltl

2.4k total citations
35 papers, 1.6k citations indexed

About

Lorenz Höltl is a scholar working on Surgery, Immunology and Oncology. According to data from OpenAlex, Lorenz Höltl has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Immunology and 13 papers in Oncology. Recurrent topics in Lorenz Höltl's work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Testicular diseases and treatments (10 papers). Lorenz Höltl is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Testicular diseases and treatments (10 papers). Lorenz Höltl collaborates with scholars based in Austria, Germany and United States. Lorenz Höltl's co-authors include Georg Bartsch, Alfred Hobisch, Reinhold Ramoner, Martin Thurnher, Georg Bartsch, Arnulf Stenzl, Christine Papesh, Claudia Zelle‐Rieser, Andreas P. Berger and Günter Janetschek and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Lorenz Höltl

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenz Höltl Austria 21 711 677 465 403 304 35 1.6k
Patricia C. Ewing Netherlands 23 402 0.6× 340 0.5× 296 0.6× 417 1.0× 91 0.3× 43 1.5k
Hemant Tongaonkar India 22 660 0.9× 87 0.1× 292 0.6× 267 0.7× 431 1.4× 78 1.5k
Carme Mallofré Spain 25 752 1.1× 86 0.1× 535 1.2× 502 1.2× 283 0.9× 67 1.6k
Olaf Reich Austria 25 606 0.9× 128 0.2× 515 1.1× 370 0.9× 244 0.8× 110 2.3k
Nader Husseinzadeh United States 18 256 0.4× 278 0.4× 296 0.6× 270 0.7× 82 0.3× 48 1.2k
Ken Kikuchi Japan 16 350 0.5× 331 0.5× 420 0.9× 121 0.3× 176 0.6× 35 971
Kota Okinaga Japan 21 454 0.6× 186 0.3× 777 1.7× 201 0.5× 325 1.1× 64 1.3k
Ilka Fuchs Germany 22 205 0.3× 288 0.4× 228 0.5× 181 0.4× 168 0.6× 40 1.4k
C. A. Makin United Kingdom 13 317 0.4× 73 0.1× 252 0.5× 195 0.5× 138 0.5× 24 972
S. B. MORRIS United Kingdom 9 305 0.4× 474 0.7× 595 1.3× 308 0.8× 383 1.3× 17 1.3k

Countries citing papers authored by Lorenz Höltl

Since Specialization
Citations

This map shows the geographic impact of Lorenz Höltl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Höltl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Höltl more than expected).

Fields of papers citing papers by Lorenz Höltl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenz Höltl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Höltl. The network helps show where Lorenz Höltl may publish in the future.

Co-authorship network of co-authors of Lorenz Höltl

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenz Höltl. A scholar is included among the top collaborators of Lorenz Höltl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenz Höltl. Lorenz Höltl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santis, Maria De, Thomas Bauernhofer, Franz Stoiber, et al.. (2016). Circulating tumor cells (CTC) and HER-2 status on CTC and primary tumor in urothelial cancer (UC) patients refractory to platinum based chemotherapy.. Journal of Clinical Oncology. 34(15_suppl). 4520–4520. 2 indexed citations
2.
Falkensammer, Claudia E., Martina Hager, Herbert Maier, et al.. (2005). Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma. Urology. 65(1). 175–175. 24 indexed citations
3.
Jöhrer, Karin, Claudia Zelle‐Rieser, Alexander Perathoner, et al.. (2005). Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma. Clinical Cancer Research. 11(7). 2459–2465. 88 indexed citations
4.
Höltl, Lorenz, Reinhold Ramoner, Claudia Zelle‐Rieser, et al.. (2004). Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide. Cancer Immunology Immunotherapy. 54(7). 663–670. 102 indexed citations
5.
Pütz, Thomas, Hubert Gander, Reinhold Ramoner, et al.. (2004). Generation of Clinical-Grade Monocyte-Derived Dendritic Cells Using the CliniMACS System. Humana Press eBooks. 109. 71–82. 7 indexed citations
6.
Pütz, Thomas, Reinhold Ramoner, Hubert Gander, et al.. (2004). Monitoring of CD4+ and CD8+ T-Cell Responses After Dendritic Cell-Based Immunotherapy Using CFSE Dye Dilution Analysis. Journal of Clinical Immunology. 24(6). 653–663. 10 indexed citations
7.
Steiner, Hannes, Reinhard Peschel, Günter Janetschek, et al.. (2004). Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology. 63(3). 550–555. 81 indexed citations
8.
9.
Steiner, Hannes, Lorenz Höltl, Andreas P. Berger, et al.. (2003). Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results. Urology. 62(3). 508–513. 97 indexed citations
10.
Stenzl, Arnulf & Lorenz Höltl. (2003). Orthotopic bladder reconstruction in women—what we have learned over the last decade. Critical Reviews in Oncology/Hematology. 47(2). 147–154. 21 indexed citations
11.
Steiner, Hannes, et al.. (2002). Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study. Urology. 60(2). 324–328. 48 indexed citations
12.
Ramoner, Reinhold, et al.. (2002). An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. Urology. 60(3). 521–526. 33 indexed citations
13.
Höltl, Lorenz, R. Peschel, Robert C. Knapp, et al.. (2002). Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology. 59(1). 114–118. 32 indexed citations
14.
Thurnher, Martin, Claudia Zelle‐Rieser, Reinhold Ramoner, Georg Bartsch, & Lorenz Höltl. (2001). The disabled dendritic cell. The FASEB Journal. 15(6). 1054–1061. 43 indexed citations
15.
Zelle‐Rieser, Claudia, Adel L. Barsoum, Federica Sallusto, et al.. (2001). EXPRESSION AND IMMUNOGENICITY OF ONCOFETAL ANTIGEN-IMMATURE LAMININ RECEPTOR IN HUMAN RENAL CELL CARCINOMA. The Journal of Urology. 165(5). 1705–1709. 18 indexed citations
16.
Hobisch, Alfred, Johann F. Kinzl, Georg Kemmler, et al.. (2000). Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World Journal of Urology. 18(5). 338–344. 90 indexed citations
17.
Rieser, Claudia, Reinhold Ramoner, Lorenz Höltl, et al.. (1999). Mature Dendritic Cells Induce T-Helper Type-1-Dominant Immune Responses in Patients with Metastatic Renal Cell Carcinoma. Urologia Internationalis. 63(3). 151–159. 58 indexed citations
18.
Rieser, Claudia, Reinhold Ramoner, Günther Böck, et al.. (1998). Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10. European Journal of Immunology. 28(8). 2283–2288. 29 indexed citations
19.
Janetschek, Günter, Alfred Hobisch, Lorenz Höltl, & Georg Bartsch. (1996). Retroperitoneal Lymphadenectomy for Clinical Stage I Nonseminomatous Testicular Tumor: Laparoscopy Versus Open Surgery and Impact of Learning Curve. The Journal of Urology. 156(1). 89–94. 90 indexed citations
20.
Reissigl, Andreas, Helmut Klocker, W. Horninger, et al.. (1996). Usefulness of the ratio free/total prostatespecific antigen in addition to total PSA levels in prostate cancer screening. Urology. 48(6). 62–66. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia C. Ewing Breakdown of academic impact, for papers by Hemant Tongaonkar Breakdown of academic impact, for papers by Carme Mallofré Breakdown of academic impact, for papers by Olaf Reich Breakdown of academic impact, for papers by Nader Husseinzadeh Breakdown of academic impact, for papers by Ken Kikuchi Breakdown of academic impact, for papers by Kota Okinaga Breakdown of academic impact, for papers by Ilka Fuchs Breakdown of academic impact, for papers by C. A. Makin Breakdown of academic impact, for papers by S. B. MORRIS
Rankless by CCL
2026